Hypothesis
GPR40 agonism would boost glucose-stimulated insulin secretion without the hypoglycemia risk of sulfonylureas.
What failed
Efficacy was strong in rodent models but did not replicate in primate islet studies.
Why
Species-specific receptor expression patterns — rodent islets over-express GPR40 relative to primate and human islets.